Literature DB >> 9259575

Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus.

T Utriainen1, P Nuutila, T Takala, P Vicini, U Ruotsalainen, T Rönnemaa, T Tolvanen, M Raitakari, M Haaparanta, O Kirvelä, C Cobelli, H Yki-Järvinen.   

Abstract

We tested the hypothesis that defects in insulin stimulation of skeletal muscle blood flow, flow dispersion, and coupling between flow and glucose uptake contribute to insulin resistance of glucose uptake in non-insulin-dependent diabetes mellitus (NIDDM). We used positron emission tomography combined with [15O]H2O and [18F]-2-deoxy--glucose and a Bayesian iterative reconstruction algorithm to quantitate mean muscle blood flow, flow heterogeneity, and their relationship to glucose uptake under normoglycemic hyperinsulinemic conditions in 10 men with NIDDM (HbA1c 8.1+/-0.5%, age 43+/-2 yr, BMI 27.3+/-0.7 kg/m2) and in 7 matched normal men. In patients with NIDDM, rates of whole body (35+/-3 vs. 44+/-3 micromol/kg body weight.min, P < 0.05) and femoral muscle (71+/-6 vs. 96+/-7 micromol/kg muscle.min, P < 0.02) glucose uptake were significantly decreased. Insulin increased mean muscle blood flow similarly in both groups, from 1.9+/-0.3 to 2.8+/-0.4 ml/100 g muscle.min in the patients with NIDDM, P < 0.01, and from 2.3+/-0.3 to 3.0+/-0.3 ml/100 g muscle.min in the normal subjects, P < 0.02. Pixel-by-pixel analysis of flow images revealed marked spatial heterogeneity of blood flow. In both groups, insulin increased absolute but not relative dispersion of flow, and insulin-stimulated but not basal blood flow colocalized with glucose uptake. These data provide the first evidence for physiological flow heterogeneity in human skeletal muscle, and demonstrate that insulin increases absolute but not relative dispersion of flow. Furthermore, insulin redirects flow to areas where it stimulates glucose uptake. In patients with NIDDM, these novel actions of insulin are intact, implying that muscle insulin resistance can be attributed to impaired cellular glucose uptake.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259575      PMCID: PMC508248          DOI: 10.1172/JCI119591

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  67 in total

1.  Contribution of impaired muscle glucose clearance to reduced postabsorptive systemic glucose clearance in NIDDM.

Authors:  J E Gerich; A Mitrakou; D Kelley; L Mandarino; N Nurjhan; J Reilly; T Jenssen; T Veneman; A Consoli
Journal:  Diabetes       Date:  1990-02       Impact factor: 9.461

2.  Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C.

Authors:  B Tesfamariam; M L Brown; R A Cohen
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

3.  Cerebral blood flow and substrate utilization in insulin-treated diabetic subjects.

Authors:  V Grill; M Gutniak; O Björkman; M Lindqvist; S Stone-Elander; R J Seitz; G Blomqvist; P Reichard; L Widén
Journal:  Am J Physiol       Date:  1990-05

4.  Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy.

Authors:  A D Baron; M Laakso; G Brechtel; S V Edelman
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Evidence for dissociation of insulin stimulation of blood flow and glucose uptake in human skeletal muscle: studies using [15O]H2O, [18F]fluoro-2-deoxy-D-glucose, and positron emission tomography.

Authors:  M Raitakari; P Nuutila; U Ruotsalainen; H Laine; M Teräs; H Iida; S Mäkimattila; T Utriainen; V Oikonen; H Sipilä; M Haaparanta; O Solin; U Wegelius; J Knuuti; H Yki-Järvinen
Journal:  Diabetes       Date:  1996-11       Impact factor: 9.461

6.  Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.

Authors:  A Mitrakou; D Kelley; T Veneman; T Jenssen; T Pangburn; J Reilly; J Gerich
Journal:  Diabetes       Date:  1990-11       Impact factor: 9.461

7.  Quantitative blood flow measurement of skeletal muscle using oxygen-15-water and PET.

Authors:  U Ruotsalainen; M Raitakari; P Nuutila; V Oikonen; H Sipilä; M Teräs; M J Knuuti; P M Bloomfield; H Iida
Journal:  J Nucl Med       Date:  1997-02       Impact factor: 10.057

8.  Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance.

Authors:  M Laakso; S V Edelman; G Brechtel; A D Baron
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

9.  Relationship between limb and muscle blood flow in man.

Authors:  M Raitakari; P Nuutila; U Ruotsalainen; M Teräs; E Eronen; H Laine; O T Raitakari; H Iida; M J Knuuti; H Yki-Järvinen
Journal:  J Physiol       Date:  1996-10-15       Impact factor: 5.182

10.  Local oxygen supply and blood flow regulation in contracting muscle in dogs and rabbits.

Authors:  D K Harrison; S Birkenhake; S K Knauf; M Kessler
Journal:  J Physiol       Date:  1990-03       Impact factor: 5.182

View more
  10 in total

1.  Seven days of aerobic exercise training improves conduit artery blood flow following glucose ingestion in patients with type 2 diabetes.

Authors:  Catherine R Mikus; Seth T Fairfax; Jessica L Libla; Leryn J Boyle; Lauro C Vianna; Douglas J Oberlin; Grace M Uptergrove; Shekhar H Deo; Areum Kim; Jill A Kanaley; Paul J Fadel; John P Thyfault
Journal:  J Appl Physiol (1985)       Date:  2011-07-07

2.  Voluntary wheel running selectively augments insulin-stimulated vasodilation in arterioles from white skeletal muscle of insulin-resistant rats.

Authors:  Catherine R Mikus; Bruno T Roseguini; Grace M Uptergrove; E Matthew Morris; Randy Scott Rector; Jessica L Libla; Douglas J Oberlin; Sarah J Borengasser; Angelina M Taylor; Jamal A Ibdah; Maurice Harold Laughlin; John P Thyfault
Journal:  Microcirculation       Date:  2012-11       Impact factor: 2.628

3.  Glucose metabolism during the early "flow phase" after burn injury.

Authors:  Hongzhi Xu; Yong-Ming Yu; Harry Ma; Edward A Carter; Shawn Fagan; Ronald G Tompkins; Alan J Fischman
Journal:  J Surg Res       Date:  2012-03-10       Impact factor: 2.192

4.  Sodium nitroprusside increases human skeletal muscle blood flow, but does not change flow distribution or glucose uptake.

Authors:  O P Pitkanen; H Laine; J Kemppainen; E Eronen; A Alanen; M Raitakari; O Kirvela; U Ruotsalainen; J Knuuti; V A Koivisto; P Nuutila
Journal:  J Physiol       Date:  1999-12-15       Impact factor: 5.182

5.  Hyperemic flow heterogeneity within the calf, foot, and forearm measured with continuous arterial spin labeling MRI.

Authors:  Wen-Chau Wu; Jiongjiong Wang; John A Detre; Felix W Wehrli; Emile Mohler; Sarah J Ratcliffe; Thomas F Floyd
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-02-29       Impact factor: 4.733

Review 6.  The role of blood vessels, endothelial cells, and vascular pericytes in insulin secretion and peripheral insulin action.

Authors:  Oliver C Richards; Summer M Raines; Alan D Attie
Journal:  Endocr Rev       Date:  2010-02-17       Impact factor: 19.871

7.  Heterogeneity in insulin-stimulated glucose uptake among different muscle groups in healthy lean people and people with obesity.

Authors:  Han-Chow E Koh; Stephan van Vliet; Gretchen A Meyer; Richard Laforest; Robert J Gropler; Samuel Klein; Bettina Mittendorfer
Journal:  Diabetologia       Date:  2021-01-29       Impact factor: 10.122

Review 8.  Human conditions of insulin-like growth factor-I (IGF-I) deficiency.

Authors:  Juan E Puche; Inma Castilla-Cortázar
Journal:  J Transl Med       Date:  2012-11-14       Impact factor: 5.531

9.  Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents.

Authors:  Kitt F Petersen; Sylvie Dufour; Gerald I Shulman
Journal:  PLoS Med       Date:  2005-08-16       Impact factor: 11.069

10.  Muscle microvascular dysfunction in central obesity is related to muscle insulin insensitivity but is not reversed by high-dose statin treatment.

Authors:  Geraldine F Clough; Magdalena Turzyniecka; Lara Walter; Andrew J Krentz; Sarah H Wild; Andrew J Chipperfield; John Gamble; Christopher D Byrne
Journal:  Diabetes       Date:  2009-02-10       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.